UNP
46
-4
BK
66
3
RF
47
4
KSS
51
8
ADSK
70
-4
PEG
46
5
GPC
38
3
DTE
52
7
AMGN
57
11
TGT
45
3
EXC
50
3
GWW
44
-2
AAP
26
2
NVDA
54
-6
AZO
63
11
WAT
32
-4
PSX
39
2
HES
67
5
ECL
70
-12
VLO
35
2
UNP
46
-4
BK
66
3
RF
47
4
KSS
51
8
ADSK
70
-4
PEG
46
5
GPC
38
3
DTE
52
7
AMGN
57
11
TGT
45
3
EXC
50
3
GWW
44
-2
AAP
26
2
NVDA
54
-6
AZO
63
11
WAT
32
-4
PSX
39
2
HES
67
5
ECL
70
-12
VLO
35
2
Financhill
Back

Five Below Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
28

FIVE
Five Below

Last Price:
110.52
Seasonality Move:
2.77%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
28
Five Below (FIVE) is a Sell

Is Five Below a Buy, Sell or Hold?

  • The current Five Below [FIVE] share price is $116.24. The Score for FIVE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • FIVE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FIVE Stock Price Chart

What is Five Below's stock price today?

  • The Five Below share price today is $116.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FIVE is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

FIVE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.26 Sell
Relative Strength Index (14 RSI): 35.64 Sell
Chaikin Money Flow: -280762 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (115.69 - 135.11) Sell
Bollinger Bands (100): (132.46 - 191.28) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 45.16 Sell
Chaikin Money Flow: -377368 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.89 - 42.13) Sell
Bollinger Bands (100): (40.93 - 48.81) Sell

FIVE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 114.45 Buy
20-day SMA: 123.52 Sell
50-day SMA: 136 Sell
200-day SMA: 171.28 Sell
8-day EMA: 116 Buy
20-day EMA: 122.13 Sell
50-day EMA: 136.55 Sell
200-day EMA: 165.57 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.13 Sell
20-day SMA: 40.38 Sell
50-day SMA: 41.72 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.68 Sell
20-day EMA: 40.43 Sell
50-day EMA: 41.92 Sell
200-day EMA: 43.42 Sell

Five Below Earnings Growth & FIVE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.55 per share, an increase this year of $0.86 per share, and a decrease next year of $0.34 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Five Below Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):